Zsófia Onódi

1.4k citations

25 papers · 1.0k indexed · 1 hit paper · h-index 11

Impact in

Cancer Research top 5%
- MicroRNA in disease regulation
Molecular Biology top 10%
- Extracellular vesicles in disease
- RNA Interference and Gene Delivery
- Circular RNAs in diseases
- Inflammasome and immune disorders

Papers in ⓘ

Cardiology and Cardiovascular Medicine 9
- Cardiovascular Function and Risk Factors 5
Developmental Neuroscience 1

Co-authors: Péter Ferdinandy (22 shared papers)Zoltán Giricz (9 shared papers)Edit I. Buzás (3 shared papers)Ágnes Kittel (2 shared papers)Tamás Baranyai (7 shared papers)Károly Módos (1 shared paper)Samir EL Andaloussi (1 shared paper)György Nagy (1 shared paper)
Journals: International Journal of Molecular Sciences (3 papers)ESC Heart Failure (3 papers)Cardiovascular Research (2 papers)Journal of Visualized Experiments (2 papers)Frontiers in Physiology (2 papers)
Partner nations: Hungary United States Poland

In The Last Decade

Zsófia Onódi

24 papers receiving 1.0k citations

Hit Papers

align trajectories log scale

Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods 2015 · 541 citations

Peers

Countries citing papers authored by Zsófia Onódi

Since Specialization

Citations

This map shows the geographic impact of Zsófia Onódi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zsófia Onódi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zsófia Onódi more than expected).

Fields of papers citing papers by Zsófia Onódi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zsófia Onódi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zsófia Onódi. The network helps show where Zsófia Onódi may publish in the future.

Co-authors

The 25 scholars most cited alongside Zsófia Onódi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zsófia Onódi Line = papers co-authored together Zsófia Onódi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Isolation of Exosomes from Blood Plasma: Qualitative and Quantitative Comparison of Ultracentrifugation and Size Exclusion Chromatography Methods PLoS ONE ·Tamás Baranyai, Kata Herczeg, Zsófia Onódi, István Voszka, Károly Módos, Nikolett Marton, György Nagy, Imre Mäger, Matthew J. A. Wood, Samir EL Andaloussi, Zoltán Pálinkás, Vikas Kumar, Péter Nagy, Ágnes Kittel, Edit I. Buzás, Péter Ferdinandy, Zoltán Giricz Hit paper breakdown →	2015	541
2	Isolation of High-Purity Extracellular Vesicles by the Combination of Iodixanol Density Gradient Ultracentrifugation and Bind-Elute Chromatography From Blood Plasma Frontiers in Physiology ·Zsófia Onódi, Csilla Pelyhe, Csilla Terézia Nagy, Gábor B. Brenner, Laura Almási, Ágnes Kittel, Mateja Manček‐Keber, Péter Ferdinandy, Edit I. Buzás, Zoltán Giricz	2018	182
3	AIM2-driven inflammasome activation in heart failure Cardiovascular Research ·Zsófia Onódi, Mihály Ruppert, Dániel Kucsera, Alex Ali Sayour, Viktória É. Tóth, Gábor Koncsos, Julianna Novák, Gábor B. Brenner, András Makkos, Tamás Baranyai, Zoltán Giricz, Anikó Görbe, Przemysław Leszek, Mariann Gyöngyösi, Iván Horváth, Rainer Schulz, Béla Merkely, Péter Ferdinandy, Tamás Radovits, Zoltán V. Varga	2021	70
4	Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning Cardiovascular Diabetology ·Tamás Baranyai, Csilla Terézia Nagy, Gábor Koncsos, Zsófia Onódi, Melinda Károlyi-Szabó, András Makkos, Zoltán V. Varga, Péter Ferdinandy, Zoltán Giricz	2015	58
5	Characterization of immune checkpoint inhibitor‐induced cardiotoxicity reveals interleukin‐17A as a driver of cardiac dysfunction after anti‐PD‐1 treatment British Journal of Pharmacology ·Tamás G. Gergely, Dániel Kucsera, Viktória É. Tóth, Tamás Kovács, Nabil V. Sayour, Zsófia D. Drobni, Mihály Ruppert, Balázs Petrovich, Bence Ágg, Zsófia Onódi, Nóra Fekete, Éva Pállinger, Edit I. Buzás, Laura I. Yousif, Wouter C. Meijers, Tamás Radovits, Béla Merkely, Péter Ferdinandy, Zoltán V. Varga	2022	44
6	Hidden Cardiotoxicity of Rofecoxib Can be Revealed in Experimental Models of Ischemia/Reperfusion Cells ·Gábor B. Brenner, András Makkos, Csilla Terézia Nagy, Zsófia Onódi, Nabil V. Sayour, Tamás G. Gergely, Bernadett Kiss, Anikó Görbe, Éva Sághy, Zoltán Zádori, Bernadette Lázár, Tamás Baranyai, Richárd Varga, Zoltán Husti, András Varró, László Tóthfalusi, Rainer Schulz, István Baczkó, Zoltán Giricz, Péter Ferdinandy	2020	18
7	Activity-based protein profiling of the human failing ischemic heart reveals alterations in hydrolase activities involving the endocannabinoid system Pharmacological Research ·Annelot C. M. van Esbroeck, Zoltán V. Varga, Xinyu Di, Eva J. van Rooden, Viktória É. Tóth, Zsófia Onódi, Mariusz Kuśmierczyk, Przemysław Leszek, Péter Ferdinandy, Thomas Hankemeier, Mario van der Stelt, Pál Pacher	2019	15
8	Drug repurposing for cardiovascular diseases: New targets and indications for probenecid British Journal of Pharmacology ·Zsófia Onódi, Sheryl E. Koch, Jack Rubinstein, Péter Ferdinandy, Zoltán V. Varga	2022	13
9	Inflammasome Activation in End-Stage Heart Failure-Associated Atrial Fibrillation ESC Heart Failure ·Szilvia Kugler, Zsófia Onódi, Mihály Ruppert, Alex Ali Sayour, Attila Oláh, Kálmán Benke, Péter Ferdinandy, Béla Merkely, Tamás Radovits, Zoltán V. Varga	2022	12
10	Characterization of the CDAA Diet-Induced Non-alcoholic Steatohepatitis Model: Sex-Specific Differences in Inflammation, Fibrosis, and Cholesterol Metabolism in Middle-Aged Mice Frontiers in Physiology ·Dániel Kucsera, Viktória É. Tóth, Dorottya Gergő, Imre Vörös, Zsófia Onódi, Anikó Görbe, Péter Ferdinandy, Zoltán V. Varga	2021	12
11	Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection Frontiers in Pharmacology ·Imre Vörös, Éva Sághy, Krisztina Pohóczky, András Makkos, Zsófia Onódi, Gábor B. Brenner, Tamás Baranyai, Bence Ágg, Barnabás Váradi, Ágnes Kemény, Przemysław Leszek, Anikó Görbe, Zoltán V. Varga, Zoltán Giricz, Rainer Schulz, Zsuzsanna Helyes, Péter Ferdinandy	2021	10
12	Saxagliptin Cardiotoxicity in Chronic Heart Failure: The Role of DPP4 in the Regulation of Neuropeptide Tone Biomedicines ·Imre Vörös, Zsófia Onódi, Viktória É. Tóth, Tamás G. Gergely, Éva Sághy, Anikó Görbe, Ágnes Kemény, Przemysław Leszek, Zsuzsanna Helyes, Péter Ferdinandy, Zoltán V. Varga	2022	10
13	Droplet Digital PCR Is a Novel Screening Method Identifying Potential Cardiac G-Protein-Coupled Receptors as Candidate Pharmacological Targets in a Rat Model of Pressure-Overload-Induced Cardiac Dysfunction International Journal of Molecular Sciences ·Nabil V. Sayour, Viktória É. Tóth, Regina N. Nagy, Imre Vörös, Tamás G. Gergely, Zsófia Onódi, Noémi Nagy, Csaba Bödör, Barnabás Váradi, Mihály Ruppert, Tamás Radovits, Federico Bleckwedel, Laura C. Zelarayán, Pál Pacher, Bence Ágg, Anikó Görbe, Péter Ferdinandy, Zoltán V. Varga	2023	9
14	Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs Journal of Visualized Experiments ·Gábor B. Brenner, Zoltán Giricz, Rita Garamvölgyi, András Makkos, Zsófia Onódi, Nabil V. Sayour, Tamás G. Gergely, Tamás Baranyai, Örs Petneházy, Dénes Kőrösi, Gergő P. Szabó, Hajnalka Vágó, Zsófia Dohy, Csilla Czimbalmos, Béla Merkely, Swetlana Boldin‐Adamsky, Elena Feinstein, Iván Horváth, Péter Ferdinandy	2021	9
15	PACAP-38 and PAC1 Receptor Alterations in Plasma and Cardiac Tissue Samples of Heart Failure Patients International Journal of Molecular Sciences ·D. G. Szabó, Zsolt Sárszegi, Beáta Polgár, Éva Sághy, Dóra Reglődi, Tünde Tóth, Zsófia Onódi, Przemysław Leszek, Zoltán V. Varga, Zsuzsanna Helyes, Ágnes Kemény, Péter Ferdinandy, Andrea Tamás	2022	9
16	NASH triggers cardiometabolic HFpEF in aging mice GeroScience ·Dániel Kucsera, Mihály Ruppert, Nabil V. Sayour, Viktória É. Tóth, Tamás Kovács, Zsombor I. Hegedűs, Zsófia Onódi, Alexandra Fábián, Attila Kovács, Tamás Radovits, Béla Merkely, Pál Pacher, Péter Ferdinandy, Zoltán V. Varga	2024	8
17	Inflammasome Activity in the Skeletal Muscle and Heart of Rodent Models for Duchenne Muscular Dystrophy International Journal of Molecular Sciences ·Zsófia Onódi, Petra Lujza Szabó, Dániel Kucsera, Péter Pokreisz, Christopher Dostal, Karlheinz Hilber, Gavin Y. Oudit, Bruno K. Podesser, Péter Ferdinandy, Zoltán V. Varga, Attila Kiss	2023	6
18	Systematic analysis of different pluripotent stem cell-derived cardiac myocytes as potential testing model for cardiocytoprotection Vascular Pharmacology ·János Palóczi, Ágnes Szántai, Julianna Kobolák, István Bock, E. Ruivo, Bernadett Kiss, Renáta Gáspár, Judit Pipis, Imre Ocsovszki, Zsuzsanna Táncos, Anita Fehér, András Dinnyés, Zsófia Onódi, Rosalinda Madonna, Péter Ferdinandy, Anikó Görbe	2020	4
19	Prior cardiac ischemic injury exacerbates immune checkpoint inhibitor-induced cardiotoxicity Cardiovascular Research ·ZV Varga, Tamás G. Gergely, Zsófia D. Drobni, Tamás Kovács, Nabil V. Sayour, Viktória É. Tóth, Dániel Kucsera, Zsófia Onódi, Michael G. Kocsis, Nóra Fekete, É. Pállinger, E I Buzas, Tomas G. Neilan, Péter Ferdinandy	2024	2
20	AIM2-driven inflammasome activation in chronic heart failure European Heart Journal ·Mihály Ruppert, Zsófia Onódi, P Leszek, Veronika Tóth, Gábor Koncsos, Béla Merkely, Péter Ferdinandy, Tamás Radovits, ZV Varga	2020	2

About Zsófia Onódi

Zsófia Onódi is a scholar working on Cardiology and Cardiovascular Medicine, Developmental Neuroscience, Pathology and Forensic Medicine, Cellular and Molecular Neuroscience and Molecular Biology, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cardiovascular Function and Risk Factors (5 papers), Cardiac Ischemia and Reperfusion (4 papers), Inflammasome and immune disorders (4 papers), Peptidase Inhibition and Analysis (3 papers), Neuropeptides and Animal Physiology (3 papers), Kawasaki Disease and Coronary Complications (3 papers), Receptor Mechanisms and Signaling (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). The work is most often cited by research in Cancer Research (381 citations), Molecular Biology (814 citations), Immunology and Allergy (38 citations), Cardiology and Cardiovascular Medicine (139 citations) and Immunology (119 citations). Zsófia Onódi has collaborated with scholars based in Hungary, United States and Poland. Frequent co-authors include Péter Ferdinandy, Zoltán Giricz, Edit I. Buzás, Ágnes Kittel, Tamás Baranyai, Károly Módos, Samir EL Andaloussi, György Nagy, Imre Mäger and István Voszka. Their work appears in journals such as International Journal of Molecular Sciences, ESC Heart Failure, Cardiovascular Research, Journal of Visualized Experiments and Frontiers in Physiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact